Cargando…

Mechanism of Ganglioside Receptor Recognition by Botulinum Neurotoxin Serotype E

The botulinum neurotoxins are potent molecules that are not only responsible for the lethal paralytic disease botulism, but have also been harnessed for therapeutic uses in the treatment of an increasing number of chronic neurological and neuromuscular disorders, in addition to cosmetic applications...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masuyer, Geoffrey, Davies, Jonathan R., Stenmark, Pål
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346984/ https://www.ncbi.nlm.nih.gov/pubmed/34361086 http://dx.doi.org/10.3390/ijms22158315

Ejemplares similares

Structural and Biochemical Characterization of Botulinum Neurotoxin Subtype B2 Binding to Its Receptors
por: Davies, Jonathan R., et al.
Publicado: (2020)

Structural Analysis of Botulinum Neurotoxins Type B and E by Cryo-EM
por: Košenina, Sara, et al.
Publicado: (2021)

Structural basis for the unique ganglioside and cell membrane recognition mechanism of botulinum neurotoxin DC
por: Zhang, Sicai, et al.
Publicado: (2017)

Crystal Structure of Botulinum Neurotoxin A2 in Complex with the Human Protein Receptor SV2C Reveals Plasticity in Receptor Binding
por: Gustafsson, Robert, et al.
Publicado: (2018)

Identification and characterization of a novel botulinum neurotoxin
por: Zhang, Sicai, et al.
Publicado: (2017)

Structural characterisation of the catalytic domain of botulinum neurotoxin X - high activity and unique substrate specificity
por: Masuyer, Geoffrey, et al.
Publicado: (2018)

Development of immunodetection system for botulinum neurotoxin serotype E
por: Sarita, R., et al.
Publicado: (2018)

Structure of dual receptor binding to botulinum neurotoxin B
por: Berntsson, Ronnie P-A, et al.
Publicado: (2013)

Emerging Opportunities for Serotypes of Botulinum Neurotoxins
por: Peng Chen, Zhongxing, et al.
Publicado: (2012)

Structural analysis of Clostridium botulinum neurotoxin type D as a platform for the development of targeted secretion inhibitors
por: Masuyer, Geoffrey, et al.
Publicado: (2015)

Botulinum Neurotoxin D Uses Synaptic Vesicle Protein SV2 and Gangliosides as Receptors
por: Peng, Lisheng, et al.
Publicado: (2011)

Characterization of a membrane binding loop leads to engineering botulinum neurotoxin B with improved therapeutic efficacy
por: Yin, Linxiang, et al.
Publicado: (2020)

Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin
por: Weisemann, Jasmin, et al.
Publicado: (2016)

Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models
por: Elliott, Mark, et al.
Publicado: (2019)

High resolution crystal structures of the receptor-binding domain of Clostridium botulinum neurotoxin serotypes A and FA
por: Davies, Jonathan R., et al.
Publicado: (2018)

Botulinum Neurotoxin Serotypes Detected by Electrochemical Impedance Spectroscopy
por: Savage, Alison C., et al.
Publicado: (2015)

A neurotoxin that specifically targets Anopheles mosquitoes
por: Contreras, Estefania, et al.
Publicado: (2019)

Characterization of Serotype CD Mosaic Botulinum Neurotoxin in Comparison with Serotype C and A
por: Miyashita, Shin-Ichiro, et al.
Publicado: (2023)

Small Molecule Receptor Binding Inhibitors with In Vivo Efficacy against Botulinum Neurotoxin Serotypes A and E
por: Ben David, Alon, et al.
Publicado: (2021)

Potent Neutralization of Botulinum Neurotoxin/B by Synergistic Action of Antibodies Recognizing Protein and Ganglioside Receptor Binding Domain
por: Chen, Changchun, et al.
Publicado: (2012)

Camelid VHH Antibodies that Neutralize Botulinum Neurotoxin Serotype E Intoxication or Protease Function
por: Tremblay, Jacqueline M., et al.
Publicado: (2020)

Recombinant botulinum neurotoxin serotype A1 in vivo characterization
por: Périer, Cindy, et al.
Publicado: (2021)

Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors
por: Tao, Liang, et al.
Publicado: (2017)

Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H
por: Hackett, Gavin, et al.
Publicado: (2018)

Crystal Structures of Botulinum Neurotoxin Subtypes A4 and A5 Cell Binding Domains in Complex with Receptor Ganglioside
por: Gregory, Kyle S., et al.
Publicado: (2022)

Monoclonal Antibodies that Inhibit the Proteolytic Activity of Botulinum Neurotoxin Serotype/B
por: Fan, Yongfeng, et al.
Publicado: (2015)

A human bispecific antibody neutralizes botulinum neurotoxin serotype A
por: Lu, Jiansheng, et al.
Publicado: (2023)

Mechanism of substrate recognition by the novel Botulinum Neurotoxin subtype F5
por: Guo, Jiubiao, et al.
Publicado: (2016)

Structural basis for botulinum neurotoxin E recognition of synaptic vesicle protein 2
por: Liu, Zheng, et al.
Publicado: (2023)

Protein Domain Analysis of C. botulinum Type A Neurotoxin and Its Relationship with Other Botulinum Serotypes
por: Sharma, Shashi K., et al.
Publicado: (2009)

A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes
por: Garcia-Rodriguez, Consuelo, et al.
Publicado: (2018)

Functional EL-HN Fragment as a Potent Candidate Vaccine for the Prevention of Botulinum Neurotoxin Serotype E
por: Li, Zhen, et al.
Publicado: (2022)

Use of Monoclonal Antibodies in the Sensitive Detection and Neutralization of Botulinum Neurotoxin Serotype B
por: Cheng, Luisa W., et al.
Publicado: (2015)

Probiotic Microorganisms Inhibit Epithelial Cell Internalization of Botulinum Neurotoxin Serotype A
por: Lam, Tina I., et al.
Publicado: (2016)

Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B
por: Matsumura, Takuhiro, et al.
Publicado: (2020)

Translocation of botulinum neurotoxin serotype A and associated proteins across the intestinal epithelia
por: Lam, Tina I, et al.
Publicado: (2015)

Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co‐receptor ganglioside
por: Gregory, Kyle S., et al.
Publicado: (2020)

Iterative Structure-Based Peptide-Like Inhibitor Design against the Botulinum Neurotoxin Serotype A
por: Zuniga, Jorge E., et al.
Publicado: (2010)

Crystal Structure of Botulinum Neurotoxin Type A in Complex with the Cell Surface Co-Receptor GT1b—Insight into the Toxin–Neuron Interaction
por: Stenmark, Pål, et al.
Publicado: (2008)

A Thermostable Dissolving Microneedle Vaccine with Recombinant Protein of Botulinum Neurotoxin Serotype A
por: Zhao, Baohua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bkg8bddiqr0j3g4vo4r2d2lfss